Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
asEquivalent
b3s
b3sifp
facets
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
virtrdf-url
None
About:
http://linked.opendata.cz/resource/sukl/spc/sentence/SPC152985_doc-5-1-233-1
Goto
Sponge
Distinct
Permalink
An Entity of Type :
salt:Sentence
, within Data Space :
linked.opendata.cz
associated with source
document(s)
Type:
salt:Sentence
New Facet based on Instances of this Class
Attributes
Values
rdf:type
salt:Sentence
salt:hasEndPointer
34205
(
xsd:long
)
salt:hasTextChunk
http://linked.opendata.cz/resource/sukl/spc/text-chunk/SPC152985_doc-5-1-233-1-33562-33572
http://linked.opendata.cz/resource/sukl/spc/text-chunk/SPC152985_doc-5-1-233-1-33600-33610
http://linked.opendata.cz/resource/sukl/spc/text-chunk/SPC152985_doc-5-1-233-1-33620-33627
salt:hasStartPointer
33541
(
xsd:long
)
salt:hasOrderNumber
1
(
xsd:int
)
salt:hasText
AVF2107g Rameno 1 IRINOTEKAN/5FU/FA + Placebo Rameno 2 IRINOTEKAN/5FU/FA + Avastin a Počet pacientů 411 402 Celková doba přežití Medián (měsíce) 15.6 20.3 95% interval spolehlivosti 14.29 – 16.99 18.46 – 24.18 Poměr rizikab 0.660 p-hodnota 0.00004 Přežití bez progrese Medián (měsíce) 6.2 10.6 Poměr rizika 0.54 p-hodnota <0.0001 Podíl objektivní odpovědi Poměr (%) 34.8 44.8 95% interval spolehlivosti 30.2 – 39.6 39.9 – 49.8 p-hodnota 0.0036 Trvání odpovědi Medián (měsíce) 7.1 10.4 25–75 percentil (měsíce) 4.7 – 11.8 6.7 – 15.0 a 5 mg/kg každé 2 týdny. b V poměru ke kontrolnímu rameni.
(cs)
is
salt:hasSentence
of
http://linked.opendata.cz/resource/sukl/spc/paragraph/SPC152985_doc-5-1-233
Faceted Search & Find service v1.16.118 as of Jun 21 2024
Alternative Linked Data Documents:
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 48 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software